Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic

  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

26.21 +0.38 (+1.47%)
Official Closing Price Updated: 5:00 PM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
BNTX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
WHY: NEW YORK, NY - (NewMediaWire) - March 09, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and... 
Via TheNewswire.com
Topics Lawsuit
Exposures COVID-19 Financial Legal
Pharma Stock Roundup: Novo Nordisk's New Obesity Pill Data, Roche, AstraZeneca's Pipeline Updates
This week, data from Novo Nordisk’s early-stage study on a new weight loss pill called amycretin showed that it could be more effective than Wegovy. Meanwhile, the FDA approved Johnson & Johnson's lung... 
Via Talk Markets
Exposures Product Safety
BNTX DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
BNTX DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
WHY: NEW YORK, NY - (NewMediaWire) - March 08, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and... 
Via TheNewswire.com
Topics Lawsuit
Exposures COVID-19 Financial Legal
Pfizer Inc. (NYSE: PFE) is One of Wednesday Morning’s Most Active Stocks
Via Investor Brand Network
Exposures COVID-19
Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Monday Trading
Via Investor Brand Network
Exposures COVID-19
This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO
REGENXBIO's promising gene therapy advancements! RBC Capital Markets upgraded REGENXBIO (RGNX), citing impressive RGX-202 trial results in Duchenne patients. 
Via Benzinga
3 Stock Winners That Are Up 1,000% or More in 2024
Dig deep enough, and find a story hot enough, and you can uncover potential stock winners up 1,000%. Here are three. 
Via InvestorPlace
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Retail Traders Ditch Tesla, Apple, Google For Pharma Stocks Like Ozempic-Maker Novo Nordisk And Eli Lilly: JPMorgan
Retail traders have been observed to be selling off their shares in the 'Magnificent Seven' tech stocks, with a noticeable shift towards pharmaceutical stocks, according to a recent report by... 
Via Benzinga
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
Discover the pivotal roles of cancer-fighting biotech stocks that are advancing cancer research and subsequently, their financial growth. 
Via InvestorPlace
FDA Approves Pfizer's Leukemia Drug For Kids As Old As One Year
"FDA greenlights Pfizer's inotuzumab ozogamicin (Besponsa) for pediatric CD22-positive B-cell ALL. Study: 22/53 achieved CR with 8.2 months median duration. 
Via Benzinga
Exposures Product Safety
1 Wall Street Analyst Thinks Pfizer Stock Is Going to $45. Is It a Buy Around $26?
Betting in favor of this giant's recovery could be smart in the long term. 
Via The Motley Fool
Datuk Nadzim Johan and PPIM (Persatuan Pengguna Islam Malaysia) urge the Government of Malaysia and the Ministry of Health (KKM) to create Public Awareness around COVID-19 Information and Requirements
Via AB Newswire
Exposures COVID-19
BNTX DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
WHY: NEW YORK, NY - (NewMediaWire) - March 06, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and... 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
BNTX DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
WHY: NEW YORK, NY - (NewMediaWire) - March 06, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and... 
Via TheNewswire.com
Topics Lawsuit
Exposures COVID-19 Financial Legal
The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar
Explore the ups and downs of 3 meme stocks: Imperial Petroleum, Novavax and MicroCloud, as they navigate market challenges and speculation. 
Via InvestorPlace
Injectable HIV Treatment By ViiV Healthcare Outperforms Oral Therapy, Interim Data Shows
Findings from ViiV Healthcare's LATITUDE trial on long-acting HIV treatment. Cabenuva demonstrates superior efficacy in viral load suppression compared to daily oral therapy. Key secondary endpoints... 
Via Benzinga
What's Going On With Pfizer Stock Wednesday?
Pfizer shares were trading at 11-year lows this week, but the stock climbed higher Tuesday afternoon after Ritholtz Wealth Management's Josh Brown called it the best opportunity in the market on CNBC's... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Millionaire’s Blueprint: 7 Must-Have Stocks for Your Road to Wealthy Town
Discover must-have stocks for wealth for every investor, from healthcare and communication giants to financial and industrial sectors. 
Via InvestorPlace
Beam Therapeutics Bolts Higher on Gene Therapy Licensing Payments
Beam Therapeutics stock is rising as the company begins to receive significant money from the multiple licensing deals it has in place 
Via MarketBeat
The Top 3 Stocks for Beginners With Little Money in March 2024
Wager on these best stocks for beginners to buy, blending potential with security for those eager to make informed investment choices. 
Via InvestorPlace
Josh Brown Just Bought This Stock Trading At 11-Year Lows, Paying A 6.5% Dividend: 'They Always Find A Way To Rebuild'
Ritholtz Wealth Management's Josh Brown believes the best opportunity in the market right now is in a pharmaceutical stock that's trading at the same price it was at more than 10 years ago. 
Via Benzinga
Strong Buy Alert: Analysts Say to Scoop Up These 7 Stocks
The market is skyrocketing. These are seven of the best strong buy stocks that should have tremendous upside this year. 
Via InvestorPlace
BNTX DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
BNTX DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX
WHY: NEW YORK, NY - (NewMediaWire) - March 05, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and... 
Via TheNewswire.com
Topics Lawsuit
Exposures COVID-19 Financial Legal
Pfizer/GSK-Backed ViiV Healthcare's HIV Drug Associated With Increased Resistance, WHO Report Says
WHO's latest HIV Drug Resistance Report reveals trends in drug resistance. Discover insights on dolutegravir's impact, challenges in HIVDR monitoring, and recommendations for standardized... 
Via Benzinga
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
While red ink signals danger, for these oversold stocks ready for rebound, they could imply upside opportunities. 
Via InvestorPlace
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.